Surrogate markers in HIV disease.
The use of surrogate markers in HIV disease is an attractive method of assessing the efficacy of new treatments more quickly than by using clinical end-points. The characteristics of an ideal surrogate marker and the theoretical dangers of extrapolating properties from one class of drug to another a...
מחבר ראשי: | Peto, T |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
1996
|
פריטים דומים
-
The validity of surrogate markers in rheumatic disease.
מאת: Emery, P, et al.
יצא לאור: (1993) -
High HPgV replication is associated with improved surrogate markers of HIV progression.
מאת: Gibran Horemheb-Rubio, et al.
יצא לאור: (2017-01-01) -
Study on the functional role of immunoglobulin E as surrogate marker for HIV/AIDS infection
מאת: Sonaimuthu B, et al.
יצא לאור: (2012-09-01) -
Surrogates Markers of Insulin Resistance
מאת: Ekhlas Khalid Hameed, et al.
יצא לאור: (2022-05-01) -
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.
מאת: Timo Rath, et al.
יצא לאור: (2014-01-01)